Achim Plum

Biography

Achim Plum joined Curetis in 2015. As Chief Business Officer he is overseeing all commercial activities including global marketing and sales, business development and medical affairs. He joined from a senior management position with Siemens where he was responsible for the assessment and development of novel approaches to the in vitro diagnostics market. Prior to Siemens, Achim worked for eight years with the publicly traded German-American molecular diagnostics company Epigenomics AG, most recently as Senior Vice President Business and Strategy. At Epigenomics he built sales and marketing teams and distribution networks in Europe and the U.S., negotiated strategic commercial agreements with leading diagnostics industry players and led the company’s corporate communications and compliance functions. Following undergraduate studies at the University of Bonn (Germany) and the University of East Anglia in Norwich (UK), Achim obtained his PhD in molecular genetics from the University of Bonn in 1999 for developing and studying novel genetic models of human diseases.

Research Interest

Molecular genetics